Microinjection of orexin-A into the rat locus coeruleus nucleus induces analgesia via cannabinoid type-1 receptors

Brain Research

Volumn 1624, Issue , 2015, Pages 424-432

  Mohammad Pour Kargar, Hossein ^a   Azizi, Hossein ^a   Mirnajafi Zadeh, Javad ^a   Ali Reza, Mani ^a   Semnanian, Saeed ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

AM251; Endocannabinoid; Formalin test; Locus coeruleus nucleus; Orexin; Rat; SB 334867

Indexed keywords

ANALGESIC AGENT; CANNABINOID 1 RECEPTOR; FORMALDEHYDE; OREXIN 1 RECEPTOR; OREXIN A; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1-(2-METHYLBENZOXAZOL-6-YL)-3-(1,5)NAPHTHYRIDIN-4-YL UREA; BENZOXAZOLE DERIVATIVE; CARRIER PROTEIN; CNRIP1 PROTEIN, RAT; OREXIN; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; UREA;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; LOCUS CERULEUS; MALE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; MICROINJECTION; PAIN MEASUREMENT; PHYSIOLOGY; WISTAR RAT;

ANALGESICS; ANALYSIS OF VARIANCE; ANIMALS; BENZOXAZOLES; CARRIER PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FORMALDEHYDE; LOCUS COERULEUS; MALE; MICROINJECTIONS; OREXINS; PAIN; PAIN MEASUREMENT; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; UREA;

EID: 84955497166     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.07.050     Document Type: Article

References (66)

1. G. Aston-Jones, M. Shipley, G. Chouvet, M. Ennis, E. Van Bockstaele, V. Pieribone, R. Shiekhattar, H. Akaoka, G. Drolet, and B. Astier Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology Prog. Brain Res. 88 1991 47 75
2. H. Azhdari Zarmehri, S. Semnanian, Y. Fathollahi, E. Erami, R. Khakpay, H. Azizi, and K. Rohampour Intra-periaqueductal gray matter microinjection of orexin-A decreases formalin-induced nociceptive behaviors in adult male rats J. Pain 12 2011 280 287
3. M.M. Behbehani, M.R. Jiang, S.D. Chandler, and M. Ennis The effect of GABA and its antagonists on midbrain periaqueductal gray neurons in the rat Pain 40 1990 195 204
4. C.W. Berridge, and B.D. Waterhouse The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes Brain Res. Rev. 42 2003 33 84
5. S. Bingham, P. Davey, A. Babbs, E. Irving, M. Sammons, M. Wyles, P. Jeffrey, L. Cutler, I. Riba, and A. Johns Orexin-A, an hypothalamic peptide with analgesic properties Pain 92 2001 81 90
6. R.M. Chemelli, J.T. Willie, C.M. Sinton, J.K. Elmquist, T. Scammell, C. Lee, J.A. Richardson, S.C. Williams, Y. Xiong, and Y. Kisanuki Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation Cell 98 1999 437 451
7. J.K. Cheng, R.C. Chou, L.L. Hwang, and L.C. Chiou Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain J. Pharmacol. Exp. Ther. 307 2003 1065 1071
8. B.F. Cravatt, and A.H. Lichtman The endogenous cannabinoid system and its role in nociceptive behavior J. Neurobiol. 61 2004 149 160
9. L. De Lecea, T. Kilduff, C. Peyron, X.-B. Gao, P. Foye, P. Danielson, C. Fukuhara, E. Battenberg, V. Gautvik, and F. Bartlett The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity Proc. Natl. Acad. Sci. USA 95 1998 322 327
10. V. Di Marzo, N. Stella, and A. Zimmer Endocannabinoid signalling and the deteriorating brain Nat. Rev. Neurosci. 16 2015 30 42
11. D. Dubuisson, and S.G. Dennis The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats Pain 4 1978 161 174
12. E. Erami, H. Azhdari-Zarmehri, E. Ghasemi-Dashkhasan, M.-H. Esmaeili, and S. Semnanian Intra-paragigantocellularis lateralis injection of orexin-A has an antinociceptive effect on hot plate and formalin tests in rat Brain Res. 1478 2012 16 23
13. S.J. Gatley, A.N. Gifford, N.D. Volkow, R. Lan, and A. Makriyannis 123 I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors Eur. J. Pharmacol. 307 1996 331 338
14. D. Gervasoni, L. Darracq, P. Fort, F. Souliere, G. Chouvet, and P.H. Luppi Electrophysiological evidence that noradrenergic neurons of the rat locus coeruleus are tonically inhibited by GABA during sleep Eur. J. Neurosci. 10 1998 964 970
15. T.J. Grudt, A.N. Pol, and E.R. Perl Hypocretin-2 (orexin-B) modulation of superficial dorsal horn activity in rat J. Physiol. 538 2002 517 525
16. J.J. Hagan, R.A. Leslie, S. Patel, M.L. Evans, T.A. Wattam, S. Holmes, C.D. Benham, S.G. Taylor, C. Routledge, and P. Hemmati Orexin A activates locus coeruleus cell firing and increases arousal in the rat Proc. Natl. Acad. Sci. USA 96 1999 10911 10916
17. S. Haj-Dahmane, and R.-Y. Shen The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling J. Neurosci. 25 2005 896 905
18. G. Hervieu, J. Cluderay, D. Harrison, J. Roberts, and R. Leslie Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord Neuroscience 103 2001 777 797
19. U. Herzberg, E. Eliav, G. Bennett, and I.J. Kopin The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain Neurosci. Lett. 221 1997 157 160
20. Y.-C. Ho, H.-J. Lee, L.-W. Tung, Y.-Y. Liao, S.-Y. Fu, S.-F. Teng, H.-T. Liao, K. Mackie, and L.-C. Chiou Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition J. Neurosci. 31 2011 14600 14610
21. T. Holmqvist, L. Johansson, M. Östman, S. Ammoun, K.E. Åkerman, and J.P. Kukkonen OX1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms J. Biol. Chem. 280 2005 6570 6579
22. T.L. Horvath, S. Diano, and A.N. van den Pol Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations J. Neurosci. 19 1999 1072 1087
23. M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe Endocannabinoid-mediated control of synaptic transmission Physiol. Rev. 89 2009 309 380
24. J.P. Kukkonen Recent progress in orexin/hypocretin physiology and pharmacology Biomol. Concepts 3 2012 447 463
25. L. Liu, M. Tsuruoka, M. Maeda, B. Hayashi, and T. Inoue Coeruleospinal inhibition of visceral nociceptive processing in the rat spinal cord Neurosci. Lett. 426 2007 139 144
26. L. Liu, M. Tsuruoka, M. Maeda, B. Hayashi, X. Wang, and T. Inoue Descending modulation of visceral nociceptive transmission from the locus coeruleus/subcoeruleus in the rat Brain Res. Bull. 76 2008 616 625
27. J.N. Marcus, C.J. Aschkenasi, C.E. Lee, R.M. Chemelli, C.B. Saper, M. Yanagisawa, and J.K. Elmquist Differential expression of orexin receptors 1 and 2 in the rat brain J. Comp. Neurol. 435 2001 6 25
28. C.J. McElhinny Jr, A.H. Lewin, S.W. Mascarella, S. Runyon, L. Brieaddy, and F. Carroll Hydrolytic instability of the important orexin 1 receptor antagonist SB-334867: possible confounding effects on in vivo and in vitro studies Bioorg. Med. Chem. Lett. 22 2012 6661 6664
29. J.I. Mobarakeh, K. Takahashi, S. Sakurada, S. Nishino, H. Watanabe, M. Kato, and K. Yanai Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and-2) in mice Peptides 26 2005 767 777
30. S. Mokha, J. McMillan, and A. Iggo Descending control of spinal nociceptive transmission. Actions produced on spinal multireceptive neurones from the nuclei locus coeruleus (LC) and raphe magnus (NRM) Exp. Brain Res. 58 1985 213 226
31. A.L. Muntoni, G. Pillolla, M. Melis, S. Perra, G.L. Gessa, and M. Pistis Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons Eur. J. Neurosci. 23 2006 2385 2394
32. T. Ohno-Shosaku, H. Tsubokawa, I. Mizushima, N. Yoneda, A. Zimmer, and M. Kano Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses J. Neurosci. 22 2002 3864 3872
33. Paxinos, G., Watson, C., 2006. The rat brain in stereotaxic coordinates: hard cover edition. Vol., Academic press
34. R.G. Pertwee Cannabinoid pharmacology: the first 66 years Br. J. Pharmacol. 147 2006 S163 S171
35. C. Peyron, J. Faraco, W. Rogers, B. Ripley, S. Overeem, Y. Charnay, S. Nevsimalova, M. Aldrich, D. Reynolds, and R. Albin A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains Nat. Med. 6 2000 991 997
36. R.A. Porter, W.N. Chan, S. Coulton, A. Johns, M.S. Hadley, K. Widdowson, J.C. Jerman, S.J. Brough, M. Coldwell, and D. Smart 1, 3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor Bioorg. Med. Chem. Lett. 11 2001 1907 1910
37. H. Proudfit, and F. Clark The projections of locus coeruleus neurons to the spinal cord Prog. Brain Res. 88 1991 123 141
38. J. Putula, and J.P. Kukkonen Mapping of the binding sites for the OX1 orexin receptor antagonist, SB-334867, using orexin/hypocretin receptor chimaeras Neurosci. Lett. 506 2012 111 115
39. M. Ramanjaneya, A.C. Conner, J. Chen, P. Kumar, J.E. Brown, O. Johren, H. Lehnert, P.R. Stanfield, and H.S. Randeva Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B. J. Endocrinol. 202 2009 249 261
40. J.D. Richardson, L. Aanonsen, and K.M. Hargreaves SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice Eur. J. Pharmacol. 319 1997 R3 R4
41. J.D. Richardson, L. Aanonsen, and K.M. Hargreaves Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia J. Neurosci. 18 1998 451 457
42. T. Sakurai, A. Amemiya, M. Ishii, I. Matsuzaki, R.M. Chemelli, H. Tanaka, S.C. Williams, J.A. Richardson, G.P. Kozlowski, and S. Wilson Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior Cell 92 1998 573 585
43. W.K. Samson, B. Gosnell, J.-K. Chang, Z.T. Resch, and T.C. Murphy Cardiovascular regulatory actions of the hypocretins in brain Brain Res. 831 1999 248 253
44. E.R. Samuels, and E. Szabadi Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans Curr. Neuropharmacol. 6 2008 254 285
45. J. Sawynok, and A. Reid Antinociception by tricyclic antidepressants in the rat formalin test: differential effects on different behaviours following systemic and spinal administration Pain 93 2001 51 59
46. T.E. Scammell, and C.J. Winrow Orexin receptors: pharmacology and therapeutic opportunities Annu. Rev. Pharmacol. Toxicol. 51 2011 243 266
47. J.L. Scavone, K. Mackie, and E.J. Van Bockstaele Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors Brain Res. 1312 2010 18 31
48. D. Smart, C. Sabido-David, S. Brough, F. Jewitt, A. Johns, R. Porter, and J. Jerman SB-334867-A: the first selective orexin-1 receptor antagonist Br. J. Pharmacol. 132 2001 1179 1182
49. R.J. Smith, P. Tahsili-Fahadan, and G. Aston-Jones Orexin/hypocretin is necessary for context-driven cocaine-seeking Neuropharmacology 58 2010 179 184
50. E. Soffin, M. Evans, C. Gill, M. Harries, C. Benham, and C. Davies SB-334867-A antagonises orexin mediated excitation in the locus coeruleus Neuropharmacology 42 2002 127 133
51. N.M. Strangman, S.L. Patrick, A.G. Hohmann, K. Tsou, and J.M. Walker Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity Brain Res. 813 1998 323 328
52. A. Tanimura, M. Yamazaki, Y. Hashimotodani, M. Uchigashima, S. Kawata, M. Abe, Y. Kita, K. Hashimoto, T. Shimizu, and M. Watanabe The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase α mediates retrograde suppression of synaptic transmission Neuron 65 2010 320 327
53. P. Trivedi, H. Yu, D.J. MacNeil, L. Van der Ploeg, and X.-M. Guan Distribution of orexin receptor mRNA in the rat brain FEBS Lett. 438 1998 71 75
54. M. Tsuruoka, and W.D. Willis Jr Bilateral lesions in the area of the nucleus locus coeruleus affect the development of hyperalgesia during carrageenan-induced inflammation Brain Res. 726 1996 233 236
55. M. Tsuruoka, and W.D. Willis Descending modulation from the region of the locus coeruleus on nociceptive sensitivity in a rat model of inflammatory hyperalgesia Brain Res. 743 1996 86 92
56. P.M. Turunen, M.H. Jantti, and J.P. Kukkonen OX1 orexin/hypocretin receptor signaling through arachidonic acid and endocannabinoid release Mol. Pharmacol. 82 2012 156 167
57. J.M. Walker, and S.M. Huang Cannabinoid analgesia Pharmacol Ther. 95 2002 127 135
58. S. Watanabe, T. Kuwaki, M. Yanagisawa, Y. Fukuda, and M. Shimoyama Persistent pain and stress activate pain-inhibitory orexin pathways Neuroreport 16 2005 5 8
59. W.L. West, D.C. Yeomans, and H.K. Proudfit The function of noradrenergic neurons in mediating antinociception induced by electrical stimulation of the locus coeruleus in two different sources of Sprague-Dawley rats Brain Res. 626 1993 127 135
60. A. Woldan-Tambor, K. Bieganska, A. Wiktorowska-Owczarek, and J.B. Zawilska Activation of orexin/hypocretin type 1 receptors stimulates cAMP synthesis in primary cultures of rat astrocytes Pharmacol. Rep. 63 2011 717 723
61. C.J. Woolf Central sensitization: implications for the diagnosis and treatment of pain Pain. 152 2011 S2 S15
62. T.L. Yaksh Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing Pharmacol. Biochem. Behav. 22 1985 845 858
63. T. Yamamoto, N. Nozaki-Taguchi, and T. Chiba Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test Br. J. Pharmacol. 137 2002 170 176
64. T. Yamamoto, O. Saito, K. Shono, T. Aoe, and T. Chiba Anti-mechanical allodynic effect of intrathecal and intracerebroventricular injection of orexin-A in the rat neuropathic pain model Neurosci. Lett. 347 2003 183 186
65. D.C. Yeomans, F.M. Clark, J.A. Paice, and H.K. Proudfit Antinociception induced by electrical stimulation of spinally projecting noradrenergic neurons in the A7 catecholamine cell group of the rat Pain 48 1992 449 461
66. T. Yoshida, M. Uchigashima, M. Yamasaki, I. Katona, M. Yamazaki, K. Sakimura, M. Kano, M. Yoshioka, and M. Watanabe Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus Proc. Natl. Acad. Sci. USA 108 2011 3059 3064